Table 2. Cervical cancer stages during (September/20–January/21) and prior to (September/19–January/20) the COVID-19 pandemic, according to the 2018 FIGO Staging System.
| Period | Stage I N (%) |
Stage II N (%) |
Stage III N (%) |
Stage IVA N (%) |
Stage IVB N (%) |
p-valuea |
|---|---|---|---|---|---|---|
| September/19–January/20 (N = 60) |
12 (20.0%) |
14 (23.3%) |
16 (26.7%) |
10 (16.7%) |
8 (13.3%) |
0.328 |
| September/20–January/21 (N = 44) |
6 (13.6%) |
7 (15.9%) |
12 (27.3%) |
13 (29.5%) |
6 (13.6%) |
a
Chi-squared test